Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 28.41 USD 0.39%
Market Cap: 2.1B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one KNSA stock under the Base Case scenario is 36.86 USD. Compared to the current market price of 28.41 USD, Kiniksa Pharmaceuticals Ltd is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KNSA Intrinsic Value
36.86 USD
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Kiniksa Pharmaceuticals Ltd

Valuation History Unavailable

Historical valuation for KNSA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
Compare KNSA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KNSA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Kiniksa Pharmaceuticals Ltd

Provide an overview of the primary business activities
of Kiniksa Pharmaceuticals Ltd.

What unique competitive advantages
does Kiniksa Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Kiniksa Pharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in Kiniksa Pharmaceuticals Ltd recently?

Summarize the latest earnings call
of Kiniksa Pharmaceuticals Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kiniksa Pharmaceuticals Ltd.

Provide P/S
for Kiniksa Pharmaceuticals Ltd.

Provide P/E
for Kiniksa Pharmaceuticals Ltd.

Provide P/OCF
for Kiniksa Pharmaceuticals Ltd.

Provide P/FCFE
for Kiniksa Pharmaceuticals Ltd.

Provide P/B
for Kiniksa Pharmaceuticals Ltd.

Provide EV/S
for Kiniksa Pharmaceuticals Ltd.

Provide EV/GP
for Kiniksa Pharmaceuticals Ltd.

Provide EV/EBITDA
for Kiniksa Pharmaceuticals Ltd.

Provide EV/EBIT
for Kiniksa Pharmaceuticals Ltd.

Provide EV/OCF
for Kiniksa Pharmaceuticals Ltd.

Provide EV/FCFF
for Kiniksa Pharmaceuticals Ltd.

Provide EV/IC
for Kiniksa Pharmaceuticals Ltd.

Show me price targets
for Kiniksa Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for Kiniksa Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for Kiniksa Pharmaceuticals Ltd?

What are the Net Income projections
for Kiniksa Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for Kiniksa Pharmaceuticals Ltd?

What are the EPS projections
for Kiniksa Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for Kiniksa Pharmaceuticals Ltd?

What are the EBIT projections
for Kiniksa Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for Kiniksa Pharmaceuticals Ltd?

Compare the revenue forecasts
for Kiniksa Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kiniksa Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kiniksa Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kiniksa Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of Kiniksa Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Kiniksa Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of Kiniksa Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for Kiniksa Pharmaceuticals Ltd.

Provide ROE
for Kiniksa Pharmaceuticals Ltd.

Provide ROA
for Kiniksa Pharmaceuticals Ltd.

Provide ROIC
for Kiniksa Pharmaceuticals Ltd.

Provide ROCE
for Kiniksa Pharmaceuticals Ltd.

Provide Gross Margin
for Kiniksa Pharmaceuticals Ltd.

Provide Operating Margin
for Kiniksa Pharmaceuticals Ltd.

Provide Net Margin
for Kiniksa Pharmaceuticals Ltd.

Provide FCF Margin
for Kiniksa Pharmaceuticals Ltd.

Show all solvency ratios
for Kiniksa Pharmaceuticals Ltd.

Provide D/E Ratio
for Kiniksa Pharmaceuticals Ltd.

Provide D/A Ratio
for Kiniksa Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for Kiniksa Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for Kiniksa Pharmaceuticals Ltd.

Provide Quick Ratio
for Kiniksa Pharmaceuticals Ltd.

Provide Current Ratio
for Kiniksa Pharmaceuticals Ltd.

Provide Cash Ratio
for Kiniksa Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for Kiniksa Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for Kiniksa Pharmaceuticals Ltd?

What is the current Free Cash Flow
of Kiniksa Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kiniksa Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kiniksa Pharmaceuticals Ltd

Current Assets 355.9m
Cash & Short-Term Investments 268.3m
Receivables 40.1m
Other Current Assets 47.5m
Non-Current Assets 243.4m
PP&E 11.1m
Intangibles 16m
Other Non-Current Assets 216.4m
Current Liabilities 97.3m
Accounts Payable 2m
Accrued Liabilities 78.2m
Other Current Liabilities 17.1m
Non-Current Liabilities 44.6m
Other Non-Current Liabilities 44.6m
Efficiency

Free Cash Flow Analysis
Kiniksa Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kiniksa Pharmaceuticals Ltd

Revenue
481.2m USD
Cost of Revenue
-68.2m USD
Gross Profit
413m USD
Operating Expenses
-428.8m USD
Operating Income
-15.8m USD
Other Expenses
-1.1m USD
Net Income
-17m USD
Fundamental Scores

KNSA Profitability Score
Profitability Due Diligence

Kiniksa Pharmaceuticals Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
ROIC is Increasing
50/100
Profitability
Score

Kiniksa Pharmaceuticals Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

KNSA Solvency Score
Solvency Due Diligence

Kiniksa Pharmaceuticals Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
80/100
Solvency
Score

Kiniksa Pharmaceuticals Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd

Wall Street analysts forecast KNSA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KNSA is 36.92 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

Lowest
Price Target
30.3 USD
7% Upside
Average
Price Target
36.92 USD
30% Upside
Highest
Price Target
47.25 USD
66% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Kiniksa Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for KNSA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KNSA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KNSA stock?

The intrinsic value of one KNSA stock under the Base Case scenario is 36.86 USD.

Is KNSA stock undervalued or overvalued?

Compared to the current market price of 28.41 USD, Kiniksa Pharmaceuticals Ltd is Undervalued by 23%.

Back to Top